Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Ulla M. Marzec"'
Autor:
Ulla M. Marzec, Chenguang Zhao, Brett P. Monia, A. Robert MacLeod, Jeffrey R. Crosby, Anton Matafonov, Dacao Gao, Erik I. Tucker, David Gailani, Alexey S. Revenko, Andras Gruber, Stephen R. Hanson
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 33:1670-1678
Objective— During coagulation, factor IX (FIX) is activated by 2 distinct mechanisms mediated by the active proteases of either FVIIa or FXIa. Both coagulation factors may contribute to thrombosis; FXI, however, plays only a limited role in the arr
Autor:
Anja Buchmueller, Ulla M. Marzec, Andras Gruber, Volker Laux, Stefan Heitmeier, Elisabeth Perzborn, Hanna Tinel, Ulf Buetehorn
Publikováno v:
Thrombosis and Haemostasis. 110:162-172
SummaryRivaroxaban is an oral, direct factor Xa inhibitor for the management of thromboembolic disorders. Despite its short half-life, the ability to reverse rivaroxaban anticoagulation could be beneficial in life-threatening emergencies. The potenti
Publikováno v:
Annals of Biomedical Engineering. 38:2660-2675
Thrombogenesis depends on biochemical reactions affected by blood flow dynamics. While mathematical models of mural thrombogenesis provide a means of understanding how blood flow affects thrombus growth, comparisons to experimental data are needed to
Publikováno v:
British Journal of Haematology. 139:494-503
The minor gammaA/gamma' isoform of fibrinogen contains a high affinity binding site for thrombin exosite II that is lacking in the major fibrinogen isoform, gammaA/gammaA fibrinogen. The biological consequences of gamma' chain binding to thrombin wer
Autor:
E. Di Cera, Ulla M. Marzec, Stephen R. Hanson, Leslie A. Bush, John H. Griffin, José A. Fernández, Andras Gruber
Publikováno v:
Journal of Thrombosis and Haemostasis. 4:392-397
Anticoagulation with activated protein C (APC) reduces the mortality of severe sepsis. We investigated whether the circulating protein C (PC) pool could be utilized for sustained anticoagulation by endogenous APC. To generate APC without procoagulant
Autor:
Andras Gruber, Kenichi A. Tanaka, Andrew B. Kelly, Stephen R. Hanson, José A. Fernández, Mitsunobu Mohri, John H. Griffin, Ulla M. Marzec
Publikováno v:
British Journal of Haematology. 132:197-203
We studied whether there was a relationship between the anticoagulant effects of recombinant human soluble thrombomodulin (rhsTM) and activation of protein C in a primate model of acute vascular graft thrombosis in 11 baboons (Papio species). Baboons
Autor:
Ulla M. Marzec, Stephen R. Hanson, Thomas E. Rawson, Mark Ultsch, Linda O. Elliott, Stuart Bunting, Maureen Beresini, Richard Goldsmith, David Banner, Daniel P. Sutherlin, Canio J. Refino, Dean R. Artis, Kirk Robarge, Charles Eigenbrot, Daniel Kirchhofer, Saloumeh Kadkhodayan, Olivero Alan G, John A. Flygare, Geralyn G. DeGuzman
Publikováno v:
Journal of Biological Chemistry. 280:9160-9169
The serine protease factor VIIa (FVIIa) in complex with its cellular cofactor tissue factor (TF) initiates the blood coagulation reactions. TF.FVIIa is also implicated in thrombosis-related disorders and constitutes an appealing therapeutic target fo
Autor:
Stephen R. Hanson, Nobuyuki Katori, Kenichi A. Tanaka, Andrew B. Kelly, Harry F. Kotze, Ulla M. Marzec
Publikováno v:
Thrombosis Research. 115:79-87
Background The occurrence of thrombocytopenia has been reported during clinical eptifibatide (Integrilin) therapy, but the exact mechanism is not yet established to explain the varied duration and severity of thrombocytopenia associated with glycopro
Autor:
Feng Gao, Charles B. Nemeroff, Dominique L. Musselman, Sasikanth Duggirala, Ulla M. Marzec, Stephen R. Hanson, Hannah Larsen, Andrea Reemsnyder, Amita K. Manatunga, Robert W. Taylor, Madalyn Davidoff
Publikováno v:
Depression and Anxiety. 15:91-101
Relatively little is known concerning the magnitude of alterations of platelet activation and secretion markers of patients with major depression when compared to patients at increased risk for, or with current, clinically significant atherosclerosis
Autor:
Kathryn A. McKenna, Jeremy J. Glynn, Ulla M. Marzec, Deirdre E.J. Anderson, Monica T. Hinds, Stephen R. Hanson
Publikováno v:
Cells, tissues, organs. 199(4)
There is significant clinical need for viable small-diameter vascular grafts. While there are many graft biomaterials in development, few have been clinically successful. Evaluation of grafts with a clinically relevant model is needed to drive develo